Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/5/2020
SIETES contiene 93011 citas

 
 
<< anterior 41 a 60 de 240 siguiente >>
Presentar resultados
Seleccionar todas
41.Tiene citas relacionadas Cita con resumen
Shenfield GM, Jacka J. Adverse drug reactions. Lancet 2001;357:561. [Ref.ID 55214]
42. Cita con resumen
Sewell WAC. Drug-induced aseptic meningitis. Adv Drug React Bull 2000;205:783-6. [Ref.ID 54253]
43. Cita con resumen
Williams D, Feely J. Influence of media and regulatory changes on prescribing of cotrimoxazole and trimethoprim in Ireland. Pharmacoepidemiol Drug Saf 2000;9:313-7. [Ref.ID 53173]
44. Cita con resumen
Becerril E, Iñesta A, Gil A. Utilización de medicamentos en un dispensario rural africano de la República de Benin. Aten Farmaceutica 2000;2:304-9. [Ref.ID 53093]
45.Tiene citas relacionadas Cita con resumen
Chosidow O. Scabies and pediculosis. Lancet 2000;355:819-26. [Ref.ID 51104]
46.
Kovacs JA, Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N Engl J Med 2000;342:1416-29. [Ref.ID 50901]
47. Cita con resumen
Menniti-Ippolito F, Raschetti R, Da Cas R, Giaquinto C, Cantarutti L, for the Italian Paediatric Pharmacosurveillance Multicenter Group. Active monitoring of adverse drug reactions in children. Lancet 2000;355:1613-4. [Ref.ID 50803]
48. Cita con resumen
Windecker R, Steffen J, Cascorbi I, Thürmann PA. Co-trimoxazole-induced liver and renal failure. Eur J Clin Pharmacol 2000;56:191-3. [Ref.ID 50655]
49.
Talan DA, Stamm WE, Hooton TM, Moran GJ, Burke T, Iravani A, Reuning-Sherer J, Church DA. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women. A randomized trial. JAMA 2000;283:1583-90. [Ref.ID 50078]
50.Tiene citas relacionadas Cita con resumen
Chosidow O. Scabies and pediculosis. Lancet 2000;355:819-26. [Ref.ID 49725]
52.
Grandison MK, Boudinot FD. Age-related changes in protein binding of drugs: implications for therapy. Clin Pharmacokinet 2000;38:271-90. [Ref.ID 49676]
53.
Perazella M A. Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management. Drug Saf 2000;22:227-36. [Ref.ID 49653]
54.
Jolles S, Sewell WAC, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Saf 2000;22:215-26. [Ref.ID 49652]
55.
Chyka PA, Butler AY, Holliman BJ, Herman MI. Utility of acetylcysteine in treating poisonings and adverse drug reactions. Drug Saf 2000;22:123-48. [Ref.ID 49159]
56. Cita con resumen
Anónimo. Coloration des dents par les médicaments. Prescrire 2000;20:37-8. [Ref.ID 48650]
57.
USPHS/IDSA Prevention of Opportunistic Infections Working Group. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Ann Intern Med 1999;131:873-905. [Ref.ID 48497]
58. Cita con resumen
Sturgill MG, Seibold JR, Boruchoff SE, Yeh KC, Haddix H, Deutsch P. Trimethoprim/sulfamethoxazole does not affect the steady-state disposition of indinavir. J Clin Pharmacol 1999;39:1077-84. [Ref.ID 48368]
59. Cita con resumen
Zanfi D. Deficit di glucosio-6-fosfato deidrogenasi: quali farmaci evitare?. Informazioni sui Farmaci 1999;23:139-40. [Ref.ID 48251]
60. Cita con resumen
Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E, Cocci A, Moretti U, Velo G, Leone R. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999;48:839-46. [Ref.ID 48159]
Seleccionar todas
 
<< anterior 41 a 60 de 240 siguiente >>